mGlu2/3 agonists protective_against schizophrenia

Subject: mGlu2/3 agonists
Relation: protective_against
Object: schizophrenia
p-value: —

Evidence from: primary | all sources

Evidence (1 sources)

Glutamatergic transmission in schizophrenia: from basic research to clinical practice. (2012) PMID:22297716 cited

mGlu2/3 agonists are a promising treatment for schizophrenia

confidence: 0.95